Search results for "Bromide"
showing 10 items of 591 documents
Novel poly (ionic liquid)-based anion exchange membranes for efficient and rapid acid recovery from industrial waste
2020
Abstract Owing to the less energy consumption, positive impact on the environment, and prospect of providing clean water resources, anion exchange membranes (AEMs) are promising materials for acid recovery from various industrial wastewater/effluent. Based on the diffusion dialysis process, AEMs selectively allow rapid proton permeation while efficiently retaining metal ions. To enhance the efficiency of the acid recovery process, precise control of macromolecular architecture and chemical composition that enables high hydrophilicity, proton conductivity through the membrane, and ion exchange capacity is required. In this direction, we report on the one-step fabrication of novel poly (ionic…
Synthesis of linear polyglycerols with tailored degree of methylation by copolymerization and the effect on thermorheological behavior
2017
Abstract We introduce a two-step strategy for the synthesis of linear polyglycerols (linPG-OHx/OMey) with an adjustable degree of methylation ( y = D M 100 ). Ethoxy ethyl glycidyl ether (EEGE) and glycidyl methyl ether (GME) were copolymerized via the “activated monomer” polymerization technique, using tetraoctylammonium bromide (NOct4Br) as an initiator and triisobutylaluminum (i-Bu3Al) as a catalyst under mild conditions. Subsequent acidic cleavage of the acetal protective groups generates linear polyglycerols with different degree of methylation (DM) by varying the GME comonomer content between 10 and 91%. Size exclusion chromatography (SEC) evidenced good control over molecular weight …
A Challenging Comonomer Pair: Copolymerization of Ethylene Oxide and Glycidyl Methyl Ether to Thermoresponsive Polyethers
2014
Motivated by the oxygen-rich and fully amorphous structure of poly(glycidyl methyl ether) (PGME), a series of thermoresponsive poly(glycidyl methyl ether-co-ethylene oxide) copolymers P(GME-co-EO) with molecular weights in the range of 3000–20 000 g mol–1 were synthesized by the activated monomer polymerization technique. Tetraoctylammonium bromide (NOct4Br) was employed as an initiator in combination with triisobutylaluminum (i-Bu3Al) as a catalyst under mild conditions. Polyethers with varying GME content between 31 and 100 mol % were obtained. Triad sequence analysis using 13C NMR spectroscopy proved that no pronounced block structure was obtained. Differential scanning calorimetry (DSC)…
Synthesis of multiarm star poly(glycerol)-block-poly(2-hydroxyethyl methacrylate).
2006
Well-defined multiarm star block copolymers poly(glycerol)-b-poly(2-hydroxyethyl methacrylate) (PG-b-PHEMA) with an average of 56, 66, and 90 PHEMA arms, respectively, have been prepared by atom transfer radical polymerization (ATRP) of HEMA in methanol by a core-first strategy. The hyperbranched macroinitiators employed were prepared on the basis of well-defined hyperbranched polyglycerol by esterification with 2-bromoisobutyryl bromide. Polydispersites M(w)/M(n) of the new multiarm stars were in the range of 1.11-1.82. Unexpectedly, with the combination of CuCl/CuBr(2)/2,2'-bipyridyl as catalyst, the polymerization conversion can be driven to maximum values of 79%. The control of CuCl cat…
Epicyanohydrin: Polymerization by Monomer Activation Gives Access to Nitrile-, Amino-, and Carboxyl-Functional Poly(ethylene glycol)
2015
Both homo- and copolymerization of the hitherto nonpolymerizable epoxide monomer epicyanohydrin (EPICH) with ethylene oxide (EO) have been studied, employing the monomer activation technique. Tetraoctylammonium bromide or tetrabutylammonium iodide was used as initiator combined with i-Bu3Al to activate the EPICH monomer. The EPICH content was varied from 4 to 16 mol %, yielding well-defined PEG-co-PEPICH copolymers with molecular weights Mn (SEC) ranging from 3700 to 8800 g mol–1. The nitrile groups of the resulting polyethers were further reduced or hydrolyzed to introduce amino, amide, or carboxyl groups at the polyether backbone, circumventing protecting group chemistry. Successful trans…
Calorimetric and Volumetric Investigations of the Effect of the Hydrophobicity of the Surfactant on the Binding between (Ethylene oxide)13-(propylene…
2004
The enthalpy and the volume of transfer (DeltaY(t)) of the unassociated (ethylene oxide)(13)-(propylene oxide)(30)-(ethylene oxide)(13) (L64) from water to the aqueous sodium alkanoate solutions as functions of the surfactant concentrations (m(S)) were determined at 298 K. The surfactants studied are sodium hexanoate, sodium heptanoate, sodium octanoate, sodium undecanoate, and sodium dodecanoate. As a general feature, for the short alkyl chain surfactants, DeltaY(t) describes an S-shaped curve in the range of m(S) analyzed whereas for the more hydrophobic surfactants the DeltaY(t) vs m(S) trends exhibit maxima which appear at ms values very close to the critical micellar concentration in w…
A dose-ranging study of indacaterol in obstructive airways disease, with a tiotropium comparison.
2008
This dose-ranging study assessed the bronchodilator efficacy and tolerability of indacaterol, a novel once-daily inhaled beta2-agonist, in subjects clinically diagnosed with COPD. Comparative data with tiotropium were collected. In the double-blind, core period of the study, 635 subjects with COPD (prebronchodilator FEV(1)40% of predicted and > or =1.0L; FEV1/FVC <70%) were randomized to receive indacaterol 50, 100, 200 or 400microg or placebo via multi-dose dry powder inhaler, or indacaterol 400microg via single-dose dry powder inhaler, once daily for 7 days. After completing double-blind treatment and washout, a subset of subjects from each treatment group entered an open-label extension …
Efficacy of once-daily tiotropium Respimat in adults with asthma at GINA Steps 2-5.
2020
Tiotropium Respimat is an efficacious add-on to maintenance treatment in patients with symptomatic asthma. Currently, the Global Initiative for Asthma (GINA) strategy recommends tiotropium for patients at Steps 4–5. To assess the clinical benefits of tiotropium Respimat across asthma severities, GINA Steps 2–5, a post hoc analysis of five double-blind trials (12–48-weeks; patients aged 18–75 years) investigated the effect of tiotropium Respimat, 5 μg or 2.5 μg, versus placebo, on peak forced expiratory volume in 1 s (FEV1) within 3 h post-dose (FEV1(0–3h)) response, and Asthma Control Questionnaire-7 (ACQ-7) responder rate. GINA step grouping was based on patients’ background treatment regi…
Tiotropium - ein langwirksames, inhalatives Anticholinergikum zur Therapie der chronisch-obstruktiven Lungenerkrankung (COPD)
2003
Anticholinergics are agents of first choice for the symptomatic treatment of patients with COPD. Tiotropium (Ba 679 BR, Spiriva) is a long-acting inhaled anticholinergic designed for once-daily bronchodilator treatment of COPD. Tiotropium is a selective antagonist of pulmonary M1 and M3 muscarinic receptor subtypes, that produces a long-lasting (24 hours), dose-dependent bronchodilation and bronchoprotection against constrictive stimuli, e. g. methacholine, following inhalation of single doses. Clinical trials with tiotropium in COPD patients over a maximum treatment duration of one year have confirmed a persisting bronchodilator effect of tiotropium compared with placebo and ipratropium, a…
Efficacy and safety of indacaterol and tiotropium in COPD patients according to dyspnoea severity.
2013
Background Guidelines for chronic obstructive pulmonary disease (COPD) recommend that treatment choices be based partly on symptoms. Methods A post-hoc analysis of pooled data from clinical studies compared the efficacy and safety of once-daily inhaled bronchodilators indacaterol (150 and 300 μg) and open-label tiotropium (18 μg) according to baseline dyspnoea severity on the modified Medical Research Council (mMRC) scale in patients with COPD (mMRC scores <2 = ‘less dyspnoea’; scores ≥2 = ‘more dyspnoea’). Outcomes were assessed after 26 weeks. Results The analysis included 3177 patients. In patients with less dyspnoea: indacaterol (both doses) improved 24-h post-dose (‘trough’) forced exp…